Literature DB >> 31358483

Gut microbiota, dysbiosis and colon lavage.

Lorenzo Drago1, Casini Valentina2, Pace Fabio2.   

Abstract

Gut microbial dysbiosis is considered an alteration of diversity and abundance of intestinal microbes, which contributes to the onset of many disorders. Several factors cause dysbiosis, depending on life-style (nutrition, stress, environment, smoking, physical activity) or particular diseases (inflammatory, autoimmune, chronic diseases). Drugs (i.e. antibiotics, anticancer drugs), as well as medical and surgical procedures, can often cause dysbiosis. Mechanical bowel preparations (MBP) and the so called "bowel cleansing" have an immediate impact on intestinal microbial composition. Whether these "acute" changes may lead to any clinical consequences is still unknown. It is tempting to speculate that such dysbiosis fostering events, at least in patients already presenting abdominal complaints, such as irritable bowel syndrome (IBS), or inflammatory bowel disease (IBD) patients, may drive additional or more severe symptoms. Recently, the possibility of using probiotic supplementation has been addressed in the literature, with the purpose to counteract intestinal dysfunctional changes observed in relation to a dysbiotic state. Whereas probiotics are recognized to be effective and safe in restoring gut microbiota dysbiosis, preliminary evidence suggest that this approach may prove helpful even in case of transient dysbiotic states related to colonoscopy bowel preparation.
Copyright © 2019 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Colonoscopy; Dysbiosis; Gut Microbiota; Probiotics

Mesh:

Substances:

Year:  2019        PMID: 31358483     DOI: 10.1016/j.dld.2019.06.012

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  7 in total

1.  Significant Differences in Gut Microbiota Between Irritable Bowel Syndrome with Diarrhea and Healthy Controls in Southwest China.

Authors:  Chengjiao Yao; Yilin Li; Lihong Luo; Fengjiao Xie; Qin Xiong; Tinglin Li; Chunrong Yang; Pei-Min Feng
Journal:  Dig Dis Sci       Date:  2022-05-03       Impact factor: 3.199

2.  Colonic bacterial diversity and dysbiosis in active microscopic colitis as compared to chronic diarrhoea and healthy controls: effect of polyethylene glycol after bowel lavage for colonoscopy.

Authors:  Lissette Batista; Virginia Robles; Chaysavanh Manichanh; Laura Ruiz; Danila Guagnozzi; Ferran Pinsach; Francisco Guarner; Fernando Fernández-Bañares
Journal:  BMC Gastroenterol       Date:  2022-06-28       Impact factor: 2.847

Review 3.  The gut virome in inflammatory bowel disease pathogenesis: From metagenomics to novel therapeutic approaches.

Authors:  Federica Ungaro; Luca Massimino; Silvia D'Alessio; Silvio Danese
Journal:  United European Gastroenterol J       Date:  2019-09-27       Impact factor: 4.623

Review 4.  Gut microbiota influence tumor development and Alter interactions with the human immune system.

Authors:  Yanshan Ge; Xinhui Wang; Yali Guo; Junting Yan; Aliya Abuduwaili; Kasimujiang Aximujiang; Jie Yan; Minghua Wu
Journal:  J Exp Clin Cancer Res       Date:  2021-01-25

5.  Engraftment of strictly anaerobic oxygen-sensitive bacteria in irritable bowel syndrome patients following fecal microbiota transplantation does not improve symptoms.

Authors:  Patrick Denis Browne; Frederik Cold; Andreas Munk Petersen; Sofie Ingdam Halkjær; Alice Højer Christensen; Stig Günther; Lars Hestbjerg Hansen
Journal:  Gut Microbes       Date:  2021 Jan-Dec

6.  Mucosal microbiota and gene expression are associated with long-term remission after discontinuation of adalimumab in ulcerative colitis.

Authors:  Toshiharu Sakurai; Hiroki Nishiyama; Kazuko Sakai; Marco A De Velasco; Tomoyuki Nagai; Yoriaki Komeda; Hiroshi Kashida; Akiyoshi Okada; Isao Kawai; Kazuto Nishio; Hiroyuki Ogata; Masatoshi Kudo
Journal:  Sci Rep       Date:  2020-11-05       Impact factor: 4.379

Review 7.  Molecular Mechanisms of Microbiota-Mediated Pathology in Irritable Bowel Syndrome.

Authors:  Yoshiyuki Mishima; Shunji Ishihara
Journal:  Int J Mol Sci       Date:  2020-11-17       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.